SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs steep slide to fresh lows is being tied by traders to weakening Trump-related political sentiment and the approaching midterms, with some also pointing to Truth Social engagement and the companys limited operating business. The discussion is overwhelmingly bearish, though a few traders view the decline as a potential entry point or rebound setup.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention ahead of its Q3 earnings report, with traders weighing mixed options positioning and bracing for an event-driven move. Discussion centers on whether pricing and vehicle mix can offset weaker sales and steep declines in EV demand.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Interim ARO-MAPT results showing substantial tau reduction after subcutaneous dosing have renewed attention on Arrowheads potential to deliver RNAi therapies across the blood-brain barrier. Many traders view the data as important validation of the platform, while others are frustrated by the muted share-price reaction and note that the results are early biomarker data, not evidence of clinical benefit.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is drawing attention amid a sharp AI and semiconductor selloff followed by a rebound, with traders debating whether the weakness is a temporary unwind or a warning that debt-heavy data-center spending may not deliver adequate returns, particularly as CoreWeave faces credit concerns. Dip buyers point to continued GPU demand and upcoming company updates, while skeptics question the sustainability of AI infrastructure spending and Nvidias exposure to it.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

CEO Angelos Stergious early anniversary LinkedIn post has traders speculating that major news may be near, including a REGAL trial update or a possible buyout; skeptics see it as a routine anniversary message, not a confirmed signal. Discussion centers on the blinded Phase 3 REGAL trial nearing its final-analysis trigger, with the timing and outcome still uncertain.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United is drawing attention for CEO Scott Kirbys comments backing a near-100% inheritance tax, which have prompted some traders to call for a boycott or selloff while others dismiss the remarks as separate from the stock. The debate is unfolding ahead of quarterly results, with traders also weighing the recent share-price pullback, fuel costs and whether demand and guidance can support earnings.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention amid a volatile rebound after a steep selloff in AI infrastructure and neocloud stocks, as traders weigh concerns about debt, funding needs and whether AI spending will generate adequate returns. Some see the decline as an oversold buying opportunity, while others warn that sector-wide pressure and financing risks could keep shares weak.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are drawing attention amid a steep post-IPO selloff, with traders pointing to newly unlocked shares, insider selling, and an analyst target cut as sources of pressure, alongside concerns about OpenAI customer concentration and the companys ability to scale. Bears expect more downside, while bulls argue the decline has left the AI-chip maker oversold and emphasize its technology and long-term potential.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas quarterly earnings miss and reduced full-year outlook, driven by surging fuel costs, dominate discussion. Traders are split between confidence in resilient travel demand and pricing power, and concern that fuel and other operating costs will keep squeezing margins.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons rally is drawing attention after Morgan Stanley named it a top pick and raised its outlook, citing accelerating AWS growth and AI-related demand. Traders welcomed the upgrade, while debating whether the jump can hold ahead of earnings and amid concerns about heavy capital spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Axon (AXON). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Axon Reports Significant Momentum Across Federal Sector as U.S. Government Fiscal Year Closes

Axon Reports Significant Momentum Across Federal Sector as U.S. Government Fiscal Year Closes Axon Reports Significant Momentum Across Federal Sector as U.S. Government Fiscal Year ClosesPR NewswireSCOTTSDALE, Ariz., Oct. 15, 2026Awards span across multiple agencies, supporting federal law...

Here's Why Axon Enterprise (AXON) Fell More Than Broader Market

Axon Enterprise (AXON) reached $407.8 at the closing of the latest trading day, reflecting a -1.34% change compared to its last close.

$1000 Invested In Axon Enterprise 5 Years Ago Would Be Worth This Much Today

Axon Enterprise (NASDAQ:AXON) has outperformed the market over the past 5 years by 6.0% on an annualized basis producing an average annual return of 17.47%. Currently, Axon Enterprise has a market capitalization ofread more...

Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know  

Recently, Zacks.com users have been paying close attention to Axon (AXON). This makes it worthwhile to examine what the stock has in store.

Can Axon Sustain EBITDA Margin Momentum Amid Cost Pressures?

Axon's EBITDA margin rises despite surging costs, fueled by robust sales and tariff refunds. Can strong demand and cost discipline sustain margin expansion?

Axon (AXON) Upgraded to Strong Buy: Here's Why

Axon (AXON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Axon Enterprise vs. Turning Point Brands: Which Slumping Stock Is a Better Rebound Candidate Right Now?

Key PointsAxon Enterprise maintains a dominant position in the public safety market through its integrated ecosystem of Taser devices and cloud software...

Axon Enterprise (AXON) Rises As Market Takes a Dip: Key Facts

In the closing of the recent trading day, Axon Enterprise (AXON) stood at $417.31, denoting a +2.79% move from the preceding trading day.

Marrero Armor LLC Secures First International Order, Expanding U.S.-Made Ballistic Protection Worldwide

Marrero Armor LLC Secures First International Order, Expanding U.S.-Made Ballistic Protection Worldwide Marrero Armor LLC Secures First International Order, Expanding U.S.-Made Ballistic Protection WorldwidePR NewswireSCOTTSDALE, Ariz., Oct. 8, 2026SCOTTSDALE, Ariz., Oct. 8, 2026 /PRNewswire...

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

AXON Plans To Raise $1B Through Convertible Notes — Here’s What Investors Need To Know

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Axon expects to give underwriters an option to purchase up to an additional $150 million of notes to cover over-allotments.</li><li>The notes will mature on Sept. 15, 2031, will carry no regular interest and will not accrete in principal.</li><li>Axon expects to enter into capped call transactions designed to generally reduce potential dilution upon conversion of the notes, subject to a cap.</li></ul><p>Axon Enterprise Inc. (AXON) shares fell around 4% in Tuesday’s premarket session after the public safety technology company announced plans to raise $1 billion through an offering of 0% convertible senior notes due 2031.</p><p>Axon also expects to grant the underwriters an option to purchase up to an additional $150 million of notes solely to cover any over-allotments.</p><h2 class="st-heading-2">Use Of Proceeds</h2><p>Axon said it intends to use a portion of the net proceeds to pay the costs of the capped call transactions tied to the notes.</p><p>The company expects to use the remaining net proceeds for general corporate purposes, including providing capital to support its growth and acquiring or investing in product lines, products, services or technologies.</p><h2 class="st-heading-2">Axon’s 0% Convertible Notes</h2><p>The notes will mature on Sept. 15, 2031, unless converted, redeemed or repurchased earlier. The notes will be senior, unsecured obligations of Axon and will not bear regular interest. The principal amount will also not accrete, the firm said.</p><p>Noteholders will have the right to convert their notes under certain circumstances and during specified periods. Upon conversion, Axon may settle the obligation in cash, common stock, or a combination of both.</p><p>The initial conversion rate and other terms of the notes will be determined when the offering is priced. This means the number of shares that could be involved in a future conversion cannot be determined from Tuesday's announcement alone.</p><p>Alongside the offering, Axon said it expects to enter into privately negotiated capped call transactions with one or more financial institutions.</p><p>The capped calls will cover the number of shares initially underlying the notes, subject to anti-dilution adjustments.</p><p>Axon said the transactions are generally designed to reduce potential dilution of its common stock upon conversion of the notes and/or to offset certain cash payments it may be required to make above the principal amount of the converted notes, subject to a cap.</p><h2 class="st-heading-2">Axon’s Existing Debt And Cash Position</h2><p>As of June 30, 2026, Axon reported $685 million in cash, cash equivalents and short-term investments and $1.8 billion of outstanding senior notes, leaving the company with a net debt position of approximately $1.1 billion.</p><p>The new notes would therefore add to Axon's debt obligations if the proposed offering is completed, although the 0% coupon means the notes would not require regular cash interest payments.</p><h2 class="st-heading-2">Axon's Earnings Highlights</h2><p>The company reported $904 million in second-quarter (Q2) revenue, up 35% year over year, marking its 10th consecutive quarter of revenue growth above 30%. Annual recurring revenue rose 39% to $1.6 billion.</p><p>Axon reported $15.1 billion in future contracted bookings as of June 30, up 41% year over year. The company said it expected to fulfill 20% to 25% of that balance over the next 12 months, with the remainder generally expected to be fulfilled over the following 10 years.</p><p>The firm raised its full-year 2026 revenue-growth outlook to 32% to 34% from 30% to 32% previously, while maintaining its Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)&nbsp; margin outlook at approximately 25.5%.</p><h2 class="st-heading-2">Retail Take On AXON</h2><p>On Stocktwits, retail sentiment for AXON stayed ‘neutral’ over the past 24 hours.</p><p><a href="https://stocktwits.com/symbol/AXON">AXON</a> stock has dropped over 15% year-to-date.</p><p><strong>Read more: </strong><a href="https://stocktwits.com/news-articles/markets/equity/vera-stock-jumps-16-premarket-trutakna-cuts-kidney-disease-progression-risk-by-76-full-fda-filing-planned-in-q4/cZtnakYRBcI"><strong>VERA Stock Jumps 16% Premarket – Trutakna Cuts Kidney Disease Progression Risk By 76%, Full FDA Filing Planned In Q4</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

 Axon Enterprise Logo Shown on Smartphone with Latest Stock Market Chart

Axon plans to offer $1 billion of 0% convertible senior notes due 2031, with proceeds earmarked for capped call costs and general corporate purposes, including growth initiatives and potential acquisitions or investments in other businesses.

$APP

$AXON

$BROS

$CELH

$APP, $AXON, $BROS, and $CELH all sold off sharply following Q2 earnings. Which of these earnings declines are you most interested in buying? Vote and explain your reasoning in the comments.

Which of these earnings declines are you most interested in buying - $APP, $AXON, $BROS, or $CELH?

Current Price	$383.09
Prev Close	$390.29
Open	$393.92
Dividend Yield	0.00%
50-Day Moving Average	$498.94
Beta	1.23
Avg. Volume	1.09M
PE Ratio	158.66

52-Week High	$764.02
52-Week Low	$339.01
Market Capitalization	$31.71B
EPS (Annual)	$1.51
Price to Book	8.47
Revenue Per Employee	$441,196.19

Feed

News

Sentiment

Earnings

Fundamentals

Info

AXON Fundamentals